DK0921807T3 - Hydrogenholdigt lægemiddel - Google Patents

Hydrogenholdigt lægemiddel

Info

Publication number
DK0921807T3
DK0921807T3 DK97944778T DK97944778T DK0921807T3 DK 0921807 T3 DK0921807 T3 DK 0921807T3 DK 97944778 T DK97944778 T DK 97944778T DK 97944778 T DK97944778 T DK 97944778T DK 0921807 T3 DK0921807 T3 DK 0921807T3
Authority
DK
Denmark
Prior art keywords
hydrogenous
gas mixtures
hydrogen
gas
inflammatory processes
Prior art date
Application number
DK97944778T
Other languages
English (en)
Inventor
Christian Krebs
Bonn Rolf Van
Peter Germann
Manfred Eschwey
Original Assignee
Messer Griesheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19634530A external-priority patent/DE19634530A1/de
Priority claimed from DE1997134279 external-priority patent/DE19734279A1/de
Application filed by Messer Griesheim Gmbh filed Critical Messer Griesheim Gmbh
Application granted granted Critical
Publication of DK0921807T3 publication Critical patent/DK0921807T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DK97944778T 1996-08-27 1997-08-22 Hydrogenholdigt lægemiddel DK0921807T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19634530A DE19634530A1 (de) 1996-08-27 1996-08-27 Mittel und Verfahren zur Veränderung der Bildungsgeschwindigkeit und/oder Halbwertszeit reaktiver Molekülspezies
DE1997134279 DE19734279A1 (de) 1997-08-07 1997-08-07 Wasserstoffhaltiges Medikament
PCT/EP1997/004567 WO1998008523A1 (de) 1996-08-27 1997-08-22 Wasserstoffhaltiges medikament

Publications (1)

Publication Number Publication Date
DK0921807T3 true DK0921807T3 (da) 2004-03-15

Family

ID=26028775

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97944778T DK0921807T3 (da) 1996-08-27 1997-08-22 Hydrogenholdigt lægemiddel

Country Status (11)

Country Link
EP (1) EP0921807B1 (da)
JP (1) JP2000517311A (da)
CN (1) CN1191836C (da)
AT (1) ATE253372T1 (da)
DE (1) DE59710969D1 (da)
DK (1) DK0921807T3 (da)
ES (1) ES2210585T3 (da)
HK (1) HK1021885A1 (da)
HR (1) HRP970465A2 (da)
PT (1) PT921807E (da)
WO (1) WO1998008523A1 (da)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8128963B2 (en) 1996-09-27 2012-03-06 The Trustees Of Columbia University In The City Of New York Methods for treating ischemic disorders using carbon monoxide
DE19833014A1 (de) * 1998-07-23 2000-01-27 Messer Griesheim Gmbh Edelgashaltige Injektionsanästhesiemittel
US7678390B2 (en) * 1999-04-01 2010-03-16 Yale University Carbon monoxide as a biomarker and therapeutic agent
FR2812197B1 (fr) * 2000-07-27 2003-01-03 Air Liquide Sante Int Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
SI1404811T1 (sl) 2001-06-21 2009-04-30 Beth Israel Hospital Ogljikov monoksid izboljša rezultate pri presaditvi tkiva in organov ter prepreči apoptozo
JP2005525848A (ja) 2002-02-13 2005-09-02 ベス イスラエル ディコネス メディカル センター 血管疾患の治療方法
WO2003088923A2 (en) 2002-04-15 2003-10-30 University Of Pittsburgh Of The Commonwealth System Of Higher Education Methods of treating ileus
CA2482260A1 (en) 2002-04-15 2003-10-30 Beth Israel Deaconess Medical Center Inc. Use of heme oxygenase-1 and products of heme degradation
WO2003088981A1 (en) 2002-04-15 2003-10-30 University Of Pittsburgh Of The Commonwealth System Of Higher Education Methods of treating necrotizing enterocolitis
WO2004039735A1 (ja) * 2002-04-26 2004-05-13 Miz Co., Ltd. 抗酸化方法、抗酸化機能水およびその用途
CA2484770A1 (en) * 2002-05-09 2003-11-20 Yale University Carbon monoxide as a biomarker and therapeutic agent
UA83465C2 (uk) 2002-05-17 2008-07-25 Йельский Университет Спосіб лікування гепатитів монооксидом вуглецю
WO2006064539A1 (ja) * 2004-12-13 2006-06-22 Wataru Murota 還元性生理食塩水及びその製造方法
US20090035383A1 (en) 2005-08-19 2009-02-05 Shigeo Ohta Scavenger of in vivo harmful reactive oxygen species and/or free radicals
EP2057990A4 (en) 2006-08-31 2010-08-04 Ohta Shigeo A HYDROGEN MOLECULE-CONTAINING MEANS FOR IMPROVING FATTY CHANGE
DE102008054205A1 (de) * 2008-10-31 2010-05-06 Bayer Schering Pharma Aktiengesellschaft Verwendung von Helium-Sauerstoff-Gasgemischen zur Behandlung der pulmonalen arteriellen Hypertonie
EP2474327A1 (en) 2011-01-07 2012-07-11 RWTH Aachen Microdosing of ultrasound contrast agents
CA2830298C (en) 2011-03-17 2016-08-16 Transdermal Biotechnology, Inc. Topical nitric oxide systems comprising lecithin and methods of use thereof
EP2545908A1 (en) 2011-07-11 2013-01-16 RWTH Aachen Medium for microbubbles or microparticles and preparation thereof
CN103565822B (zh) * 2012-08-05 2015-03-25 熊江 氢气饱和生理盐水在制备防治腹主动脉瘤药物中的应用
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
CN103099780B (zh) * 2012-12-11 2015-11-25 中国科学院深圳先进技术研究院 制备含氢气微泡水溶液的方法,其产品及应用
WO2014140197A1 (en) 2013-03-15 2014-09-18 Westfaelische Wilhelms-Universitaet Muenster Detection of acute renal allograft rejection
EP3064211B1 (en) 2013-10-31 2020-04-01 Hirota, Masanori Sperm-motility enhancer
CN103690481B (zh) * 2013-12-23 2016-09-07 中国人民解放军第二军医大学 甲烷注射液在制备治疗缺血再灌注损伤药物中的应用
TWI590837B (zh) * 2014-03-25 2017-07-11 林信湧 一種用於治療心臟病之吸入式醫藥組成物及其備製方法
TWI590838B (zh) * 2014-04-18 2017-07-11 林信湧 一種用於治療糖尿病之吸入式醫藥組成物及其備製方法
TWI601542B (zh) 2014-04-18 2017-10-11 林信湧 一種用於治療肺癌之吸入式醫藥組成物及其備製方法
TWI586382B (zh) * 2014-04-18 2017-06-11 林信湧 一種用於治療腎臟病之吸入式醫藥組成物及其備製方法
TWI594772B (zh) * 2014-04-18 2017-08-11 林信湧 一種用於治療高血壓之吸入式醫藥組成物及其備製方法
JP2017143752A (ja) * 2016-02-15 2017-08-24 Hack Japan ホールディングス株式会社 サプリメント
CN109789160A (zh) * 2016-07-15 2019-05-21 富氢水技术有限公司 用于产生富氢的水及其他产品的组合物
CA3049278A1 (en) * 2017-01-05 2018-07-12 Warren Lee Apparatus, method, and use for ultrasound mediated microbubble delivery of pharmaceutical compositions
WO2018211474A1 (en) 2017-05-19 2018-11-22 Trudell Medical International Positive expiratory pressure device
USD874064S1 (en) 2018-05-18 2020-01-28 Trudell Medical International Mask
USD903097S1 (en) 2018-05-18 2020-11-24 Trudell Medical International Mask
CA3104889A1 (en) * 2018-07-23 2020-01-30 Nutragenom, Llc Composition and methods for generating and sustaining molecular hydrogen (h2) in aqueous systems
JP6628449B1 (ja) * 2018-07-30 2020-01-08 国立大学法人名古屋大学 閉塞性気道疾患の抑制又は軽減のための組成物
USD893806S1 (en) 2018-11-09 2020-08-18 Trudell Medical Internationl Mask and shroud
JP6667817B1 (ja) * 2019-03-13 2020-03-18 住友精化株式会社 ガス組成物及びその製造方法、並びにガス製品
JPWO2021090926A1 (da) * 2019-11-08 2021-05-14
CN113318123A (zh) * 2020-02-28 2021-08-31 MiZ株式会社 用于预防和/或改善肺炎的含分子态氢组合物
CN114948990A (zh) * 2021-02-22 2022-08-30 上海市肺科医院 氢化镁在制备防治急性呼吸窘迫综合征疾病药物中的应用
CN114870839B (zh) * 2022-02-15 2023-11-10 中国科学院上海硅酸盐研究所 具有压电催化性能的无机纳米材料和催化制氢纳米反应器及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE407778B (sv) * 1977-09-06 1979-04-23 Astra Laekemedel Ab Forpackning och forfarande for skyddande av lekemedelsaktiva losningar innehallande oxidativt nedbrytbara substanser

Also Published As

Publication number Publication date
JP2000517311A (ja) 2000-12-26
HRP970465A2 (en) 1998-08-31
PT921807E (pt) 2004-04-30
EP0921807A1 (de) 1999-06-16
WO1998008523A1 (de) 1998-03-05
ES2210585T3 (es) 2004-07-01
EP0921807B1 (de) 2003-11-05
HK1021885A1 (en) 2000-07-14
ATE253372T1 (de) 2003-11-15
DE59710969D1 (de) 2003-12-11
CN1228706A (zh) 1999-09-15
CN1191836C (zh) 2005-03-09

Similar Documents

Publication Publication Date Title
DK0921807T3 (da) Hydrogenholdigt lægemiddel
CA2198557A1 (en) Method and Apparatus for the Production of Nitric Oxide Gas Mixture
ES2140706T3 (es) Medicamentos.
NZ509328A (en) Medicinal aerosol formulations
BR9306060A (pt) Oxido nitrico de ar para usos medicos
UA27092C2 (uk) Спосіб формуваhhя дихальhої газової суміші і апарат для його реалізації
HUT64567A (en) Method for producing new cyclosporines and preparations containing said compounds as active agent
ATE301865T1 (de) Rekombinationseinrichtung
ES2036420T3 (es) Catalizador de forma monolitica o alveolar.
DE69526517D1 (de) Treibgasmischung für eine aerosolzubereitung
BR0207852A (pt) Processo para a epoxidação de olefinas
BG103221A (en) Pharmaceutical composition in aerosol form
ZA9811231B (en) New pyridylalkane alkene and alkine carboxamides substituted with a cyclic imide
ES2102012T3 (es) Procedimiento para la conversion de n2o.
FR2863169B1 (fr) Medicament gazeux inhalable a base d'argon pour le traitement des neuro-intoxications
MX9702150A (es) Dispositivo para la disminucion de monoxido de carbono de las bolsas de aire.
BR9912871A (pt) Catalisador cerâmico para a decomposição seletiva de n2o e método para a fabricação do mesmo
FR2285171A1 (fr) Procede d'elimination d'oxydes d'azote
DE60000325T2 (de) Therapeutische Verwendung eines Helium/Oxygen Gemisches, insbesondere für die Behandlung von Asthma
CZ220396A3 (en) Process of treating a medicament to aerosol, the use of a gas mixture and a therapeutical preparation
JPS6442509A (en) Method for killing slag foaming
US7629032B2 (en) Method for building up plasma on an optical fiber preform, while reducing nitrogen oxides
BR9711870A (pt) Processo para hidroxila-Æo do benzeno
BR0006237A (pt) Inalador em aerossol, e, processo de tratamentode um sujeito com um agente farmacêutico
BR0015433A (pt) Método de redução de densidade por meio de agente gerador de gás